• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Venture Capital Matters

#VentureCapital: VC meets social media

  • Pitch a Startup
  • Market Reports
  • Technologies
    • Technology Events
  • Domain Names for Startups
  • About
  • Contact

Q Bio Raises $40 Million Series B Led by Andreessen Horowitz to Bring Preventative Health and the Physical of the Future to Masses

February 20, 2020 By 3v.org Leave a Comment

Q Bio, a quantitative, clinically-relevant assessment of personal human health, today announced it has officially come out of stealth mode and secured $40 million in Series B funding led by Andreessen Horowitz. This brings Q Bio’s total funding to $58 million. This latest round of funding will allow Q Bio to continue to improve its proprietary platform and technology to make their preventive health services faster, better and more affordable for all.

“Since my own misdiagnoses over a decade ago, I’ve imagined a day when everything about a person’s body could be quickly measured, shared and analyzed. It took time but Q Bio was born,” said Jeffrey Kaditz, co-founder and CEO of Q Bio. “We are thrilled to have our current investors continue to share our vision and excitement for what is possible in the field of preventive health.”

With a mission to empower people with a deeper understanding of their body and how it’s changing, so they have more control over their health, Q Bio was founded in late 2015. The company has spent the last few years in stealth mode, focused on fine tuning its imaging protocols and determining the most clinically-relevant set of biomarkers to include in its platform that can look for existential risks in an asymptomatic population. In 75 minutes or less, members are able to get a comprehensive picture of their health and receive a web-based dashboard that they can review from anywhere in the world with their chosen clinicians. The company, based in Redwood City, quietly opened its doors to a limited membership in late 2019 and plans to open additional locations this year.

“Q Bio makes true preventive medicine possible today,” said Vijay Pande, general partner, Andreessen Horowitz. “By measuring everything from blood to imaging and more in a longitudinal way, patients can have personalized baselines and physicians the data and power to understand, interpret and utilize this data to personalize care.”

As part of this new round of funding, Pande along with Vinod Khosla from Khosla Ventures will formally join Kaditz on the company’s Board of Directors. Clarissa Shen, who joined in 2019 as Q Bio Chief Operating Officer, will also join as a Board Observer.

About Q Bio
Founded in 2015 by serial entrepreneur Jeff Kaditz, Dr. Michael Snyder and Dr. Garry Choy, Q Bio gives you a deeper understanding of your body and how it’s changing, so you have more control over your health. Q Bio’s platform is a quantitative, clinically-relevant assessment of personal human health. We believe in making preventive health available to everyone so that treatable diseases no longer take lives.

Investors include Andreessen Horowitz, Khosla Ventures, Founders Fund, Beast Ventures, Thirty5 Venturers, Sea Lane Venturers and SciFi VC. For more information, visit q.bio.

Related

Filed Under: PR Tagged With: Andreessen Horowitz, Beast Ventures, Founders Fund, Khosla Ventures, Preventative Health, Q Bio, Sea Lane Venturers, Thirty5 Venturers

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • FreshCut Secures $15M Funding to Accelerate Transformation of Web3 Gaming Content Ecosystem
  • Thought Machine Raises $160m in Series D Funding Round – Doubling Valuation to $2.7bn and Accelerating Plans to Bring World’s Banks Onto Cloud Technology
  • Foundational Skills Checklist
  • LucidLink Raises $20 Million in Series B to Solve Remote Collaboration Challenges for Global Creative Teams
  • Storyblok Raises $47M Series B Led by Mubadala Capital and HV Capital to Make Headless Content Management the New Standard
  • A bridge between Web2 and Web3
  • Fresh Technology Inc. Closes $7 Million Series A to Drive Innovation in Modern Restaurant Kitchens
  • SoftBank will be cutting its startup investments by 50-75% through March 2023
  • Paddle, which provides a billing backend for SaaS companies, raises a $200M Series D
  • RGo Robotics Exits Stealth Mode with $20M in Funding & Major Customer Wins

Media Partners

  • VPNW
  • S3H
  • OPINT
  • Press Media Release
  • OSINT
  • Digital Market
  • Briefly

Media Partners

  • Technology Conferences
  • Event Sharing Network
  • Defense Conferences
  • Cybersecurity Events
  • Event Calendar
  • Calendarial
  • Opinion
  • Venture Capital

Copyright © 2018 3V.org

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT